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Epicardial mapping and ablation have emerged in the last
decade as a strategy to increase the success rate for the
eradication of arrhythmogenic circuits in complex scar sub-
strates. It has been established that epicardial mapping and
ablation are generally required for some arrhythmic substrates
such as in arrhythmogenic right ventricular dysplasia, Brugada
syndrome, Chagas cardiomyopathy, nonischemic cardiomy-
opathy (NICM), and to a lesser extent in ischemic cardiomy-
opathy (ICM). Ablation in patients with NICM has been
shown to be inferior to that in patients with ICM, as scar
patterns are more variable with epicardial and intramural
locations. In addition, the arrhythmic mechanism of ventric-
ular tachycardia (VT) in patients with NICM is not always
macroreentrant, as focal and automatic sites of origin have
been reported in up to 20% of patients. Furthermore, deliver-
ing radiofrequency (RF) lesions in the epicardial space might
be limited because of signiﬁcant epicardial fat as well as close
proximity to phrenic nerves and coronary vasculature.
In this report, we present a case of a patient with NICM
and VT, in whom (1) a microreentrant mechanism was
demonstrated by activation and entrainment mapping and (2)
successful elimination of an epicardial circuit was achieved
with ablation through normal endocardial tissue because of
proximity of the epicardial site of origin to a coronary artery.
Case report
This is the case report of a 63-year-old man with NICM
diagnosed 8 years before admission, presumed to beKEYWORDS Ablation; Epicardial; Radiofrequency; Ventricular tachycardia
ABBREVIATIONS ICM ¼ ischemic cardiomyopathy; LV ¼ left ventricle/
ventricular; LVEF ¼ left ventricular ejection fraction; NICM ¼
nonischemic cardiomyopathy; RF ¼ radiofrequency; RV ¼ right
ventricle/ventricular; VT ¼ ventricular tachycardia
(Heart Rhythm Case Reports 2015;1:464–468)
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).secondary to viral myocarditis. The patient had a left
ventricular ejection fraction (LVEF) of 20%, had New York
Heart Association class III symptoms, and had received a
cardiac resynchronization therapy-deﬁbrillator for the pri-
mary prevention of sudden cardiac death. The patient was
brought to the emergency department after collapsing at
home, with bystander cardiopulmonary resuscitation initi-
ated. He was found to be in slow VT at 134 beats/min (cycle
length 447 ms), which was below the detection zone for his
implantable cardioverter-deﬁbrillator, and received therapy
using an automated external deﬁbrillator. In the emergency
department, he had several similar episodes, resulting in
hypotension and loss of consciousness. He required cardio-
pulmonary resuscitation and automated external deﬁbrillator
shocks on 2 more occasions. VT recurred despite intravenous
amiodarone and lidocaine.
A 12-lead electrocardiogram revealed VT with a right bundle
branch block morphology, positive concordance, and right
inferior axis. A transthoracic echocardiogram showed dilated
left ventricular (LV) left ventricular internal dimension, diastole
(LVIDd (2D) 7.12 cm) with normal wall thickness (interven-
tricular septum, diastole IVSd (2D) 0.89 cm; left ventricular
posterior wall, diastole LVPWd (2D) 1.01 cm), severe LV
diastolic dysfunction (grade III, restrictive physiology), as well as
severe LV systolic dysfunction (LVEF 23%). Subsequently, the
patient underwent emergent coronary angiography, which
showed normal coronary arteries. Positron emission tomography
with 18F-ﬂuorodeoxyglucose was negative for cardiac
sarcoidosis.
A semi-emergent invasive electrophysiology study for
ablation was performed. Clinical VT was induced with triple
extrastimuli (500/320/350) using noninvasive programmed
stimulation at the beginning of the procedure (tachycardia
cycle length 470–500 ms, right inferior axis, and right bundle
branch block pattern with R waves across the precordium).
The QRS width during VT was 290 ms, with a pseudo-delta
wave of 105 ms, an intrinsicoid deﬂection time of 174 ms,
and a maximum deﬂection index of 60%—all suggestive of
an epicardial site of origin. The coronary sinus could notpen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.07.008
KEY TEACHING POINTS
 The mechanism of ventricular tachycardia in
patients with structural heart disease is most
frequently macroreentrant. However, many
patients with a myocardial scar have focal
mechanisms and a careful analysis of entrainment
can be helpful in determining the most desirable
timing of the successful ablation site.
 Epicardial ablation is frequently limited by close
proximity to coronary arteries and epicardial
adipose tissue. Alternative strategies and
technologies are needed to address these substrate
locations.
 Prolonged high-power ablation from the
endocardium may create a deeper lesion to target
remote locations across the myocardial wall, and
early termination should not be expected during
radiofrequency delivery in such cases. Optimal
biophysical parameters require further clariﬁcation
to maintain safety.
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and tortuous anatomy. A 2-mm spacing decapolar catheter
(CARTO 3, Biosense Webster Inc, Diamond Bar, CA) was
used to map the endocardium and epicardium. Subxiphoid
epicardial access was obtained using a Tuohy epidural
needle. After epicardial access, an LV and right ventricular
(RV) epicardial voltage map (539 points) was obtained,
which showed a small area of scar in the LV basal antero-
lateral wall (Figure 1). Intravenous heparin was administered
for a retrograde aortic approach; a high-density endocardial
LV electroanatomic map (282 points) was created, which
revealed no endocardial scar (Figure 1). A small perivalvular
scar was seen on the basal anterolateral region of the
epicardium with split and fractionated electrograms. Activa-
tion mapping revealed the earliest site of activation in the
basal anterior epicardial LV wall (50 ms) (Figure 1). The
best pace maps of clinical VT were noted in close proximity
to the basal anterolateral LV scar. Concealed entrainment
was also observed in this area (Figure 1).
In order to assess the mechanism of tachycardia, entrain-
ment mapping was performed from the RV apex. There was
evidence of progressive fusion from the endocardial RV apex
with pacing at different rates (Figure 2). The QRS width was
narrower with lower limb lead amplitudes during overdrive
pacing at 430 ms compared to 390 ms. This is highly
suggestive of the presence of both constant and progressive
fusion. The earliest site was mapped to the epicardium with a
focal propagation (Online Supplemental Video 1). It was felt
that the mechanism of arrhythmia was microreentrant, and
therefore, unmapped sites with mid-diastolic activation were
unlikely to be found. Left coronary angiography revealed that
this site was close to the second diagonal artery (Figure 1).The ablation catheter (4-mm ThermoCool DF) was positioned
endocardially directly opposite to the earliest epicardial
activation site, where activation was seen just after the QRS
onset (Figure 1). Of note, entrainment mapping from the
endocardium revealed overt fusion. Ablation was performed
in the power mode setting at 50 W (temperature o421C).
Termination was noted at 24 seconds during the ﬁrst lesion
(90 seconds), but VTwas reinducible and a second application
(90 seconds) was delivered where termination was observed
again at 26 seconds (Figure 3). Another consolidation RF
lesion was delivered with a total RF time of 4 minutes.
Biophysical changes with signiﬁcant impedance drops
(430 Ω) were observed during ablation 1 and 2. No steam
pops were observed. VT was no longer inducible with triple
extrastimuli in the RV and epicardial/endocardial LV at
different sites. Antiarrhythmic agents were discontinued, and
the patient has remained free fromVT recurrence at 10months
of follow-up.
Discussion
We present this case report to highlight the following:1. Arrhythmias in scar-related cardiomyopathy should not
be assumed to be macroreentrant.2. Coronary arteries remain a signiﬁcant anatomical limi-
tation in patients with NICM and arrhythmias arising
from the LV summit.3. Prolonged endocardial high-power RF applications can
be an effective therapeutic alternative for eliminating
remote sites of origin.
Overall, it is estimated that VT ablation requires epicardial
ablation in 13% of patients with a risk of 5% and 2% of acute
and delayed major complications related to epicardial access,
respectively.1 RF ablation in the epicardial space for basal
anterolateral substrates is frequently limited by a variety of
factors including thick epicardial fat, close proximity to the
phrenic nerve, and coronary vasculature as well as inability to
deliver high power because of poor cooling.
Studies recommend avoidance of RF ablation within 5
mm of coronary arteries, as injury has been reported in
animal models and human cases.2 As in the case presented in
this report, our target was in the vicinity of a medium caliber
diagonal artery. The options for RF ablation at this point
were limited, since the coronary sinus could not be cannu-
lated distally (LV lead and narrow lumen). Options included
a hybrid procedure using a limited lateral thoracotomy with
direct visualization,3 sacriﬁcing the artery in a patient with
already severely impaired LVEF, or implementing more
aggressive measures such as bilateral cervicothoracic sym-
pathectomy (ie, resection of the lower half of the stellate
ganglion and the ﬁrst 4 thoracic ganglia via thoracoscopy)
and renal artery sympathetic denervation.4,5 Cryotherapy
might be useful for epicardial VT ablation to decrease the
risk of coronary artery injury and, in theory, to improve lesion
Figure 1 Electroanatomic mapping with bipolar endocardial and epicardial voltage. Activation mapping on the epicardium showed focal propagation. Top:
Left posterolateral view of endocardial and epicardial voltage map of LV. Left lateral view of epicardial activation mapping indicating earliest activation site in
red (-50 ms). Bottom: Concealed entrainment from earliest site. TCL was 451ms and pacing was carried out at 430 ms. Post pacing interval (PPI) was 470. TCL-
PPI: 15 ms. EGM-QRS=S-QRS(50 ms). Two ﬂuoroscopic views demonstrate proximity to a diagonal coronary artery.
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cardiac vein and the anterior interventricular vein course in the
basal part of the epicardial surface of the LV has been shown
to be a successful ablation site in patients with premature
ventricular contractions and VT. It is tempting to hypothesize
that some epicardial VTs may arise close to the coronary
venous system, which may therefore be a suitable site to map
and ablate these arrhythmias. Application of RF energy within
the coronary venous system raises concern for thermal injury
to the vein itself or to the neighboring coronary arteries, and
isolated reports have documented the risk of venous stenosis,
vein rupture, thrombosis, and even acute coronary occlusion.7
Similarly, the left phrenic nerve may be vulnerable when
ablating in the vicinity of the obtuse marginal vein or the great
cardiac vein.8
Irrigated catheters have been demonstrated to allow
more power to be delivered before temperatures reach a point
in which thrombus/clots are formed. This report describes the
feasibility of transmural ablation from the endocardium for
epicardial circuits with longer RF applications at higher power
(Online Supplemental Video 2). Yokokawa et al9 have
described ablation of epicardial VT from nonepicardial sites,where 3 patients were described to have success with endo-
cardial ablation alone. Komatsu et al10 recently evaluated the
feasibility and safety of epicardial substrate elimination by
delivering endocardial RF energy in patients with scar-related
VT, where endocardial ablation could abolish all epicardial
local abnormal ventricular activity (LAVA) in 4 patients with
ICM and 2 patients with arrhythmogenic right ventricular
cardiomyopathy (ARVC) whereas all patients with NICM
required epicardial ablation. Endocardial ablation was able to
eliminate epicardial LAVA at least partially in 15 patients with
ICM (83%), 11 with arrhythmogenic right ventricular cardio-
myopathy (ARVC) (73%), and 2 with NICM (13%), contribu-
ting to a signiﬁcant reduction in epicardial RF applications.
ADDIN EN.CITE ADDIN EN.CITE.DATA 10 Prolonged
endocardial ablation with an impact on epicardial substrate
may be one reason that the need for epicardial ablation is
currently underestimated.
Although standard RF applications have been shown to
reach a maximum lesion size between 20 and 60 sec-
onds, irrigated ablation has the potential to create deeper
lesions with longer duration applications. Nakagawa et al11
demonstrated a continuing steep rise in tissue temperature at
Figure 2. Constant fusion and subtle progressive fusion is demonstrated with pacing from the RV apex at different rates (390 ms and 430 ms) supporting a
reentrant mechanism.
Figure 3. Endocardial ablation across from the earliest region of epicardial activation. The endocardial site is just after the onset of the QRS. Delayed
termination (24s, 26s) was seen on two occasions and the patient was rendered noninducible.
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preparation. Furthermore, extending the duration of RF
delivery may overcome intermittent tissue contact, as Olson
et al12 demonstrated comparable lesion size between con-
stant contact at 60 seconds and intermittent contact lesions at
90 seconds. Additional studies are required to understand the
maximum effective duration of irrigated ablation.
The theoretical advantage of prolonged high-power ablation
must be weighed against the potential risks of char or thrombus
formation and steam pops. In a retrospective analysis of RF
applications, Seiler et al13 demonstrated that 80% of steam pops
were associated with an impedance drop of418 Ω. However,
there was signiﬁcant overlap between those with and without
steam pops (22 7Ω vs 18 8Ω) and 31% of the lesions that
did not result in steam pops had an impedance of 418 Ω.
Although tissue temperature is not always correlated with the
catheter-tissue interface temperature via irrigated technology, it
is our institutional practice to set a maximum catheter temper-
ature to 451C and carefully observe for sudden increases and
decreases in impedance. In this particular case, we did not
observe a speciﬁc impedance drop cutoff, as this was a “bailout”
option and this strategy should be reserved for cases that fail
traditional approaches. Further studies to characterize and guide
long-duration, high-powered lesions in animal models may be
helpful to optimize safety and efﬁcacy of this strategy.
Appendix
Supplementary data
Supplementary material cited in this article is available
online at http://dx.doi.org/10.1016/j.hrcr.2015.07.008.References
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